1. Home
  2. XERS vs FSBC Comparison

XERS vs FSBC Comparison

Compare XERS & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • FSBC
  • Stock Information
  • Founded
  • XERS 2005
  • FSBC 2002
  • Country
  • XERS United States
  • FSBC United States
  • Employees
  • XERS N/A
  • FSBC N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • FSBC Banks
  • Sector
  • XERS Health Care
  • FSBC Finance
  • Exchange
  • XERS Nasdaq
  • FSBC Nasdaq
  • Market Cap
  • XERS 628.7M
  • FSBC 581.0M
  • IPO Year
  • XERS 2018
  • FSBC 2021
  • Fundamental
  • Price
  • XERS $5.16
  • FSBC $28.54
  • Analyst Decision
  • XERS Strong Buy
  • FSBC Buy
  • Analyst Count
  • XERS 5
  • FSBC 4
  • Target Price
  • XERS $6.10
  • FSBC $34.75
  • AVG Volume (30 Days)
  • XERS 2.3M
  • FSBC 52.5K
  • Earning Date
  • XERS 05-08-2025
  • FSBC 04-28-2025
  • Dividend Yield
  • XERS N/A
  • FSBC 2.87%
  • EPS Growth
  • XERS N/A
  • FSBC N/A
  • EPS
  • XERS N/A
  • FSBC 2.27
  • Revenue
  • XERS $222,551,000.00
  • FSBC $124,973,000.00
  • Revenue This Year
  • XERS $31.75
  • FSBC $24.73
  • Revenue Next Year
  • XERS $21.09
  • FSBC $13.73
  • P/E Ratio
  • XERS N/A
  • FSBC $12.29
  • Revenue Growth
  • XERS 29.88
  • FSBC 11.14
  • 52 Week Low
  • XERS $1.72
  • FSBC $21.72
  • 52 Week High
  • XERS $6.07
  • FSBC $35.13
  • Technical
  • Relative Strength Index (RSI)
  • XERS 63.30
  • FSBC 62.30
  • Support Level
  • XERS $4.26
  • FSBC $25.70
  • Resistance Level
  • XERS $4.77
  • FSBC $29.84
  • Average True Range (ATR)
  • XERS 0.28
  • FSBC 1.13
  • MACD
  • XERS 0.08
  • FSBC 0.23
  • Stochastic Oscillator
  • XERS 91.32
  • FSBC 69.24

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.

Share on Social Networks: